Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TNGX Tango Therapeutics, Inc.	$258M	$0 0.0% of portfolio	0	Q3 2024 New
TARS Tarsus Pharmaceuticals, Inc.	$1.4B	$0 0.0% of portfolio	0	Q3 2024 New
TSHA Taysha Gene Therapies, Inc.	$85.1M	$0 0.0% of portfolio	0	Q3 2024 New
TPST Tempest Therapeutics, Inc.	$9.59M	$0 0.0% of portfolio	0	Q3 2024 New
TNYA Tenaya Therapeutics, Inc.	$60.4M	$0 0.0% of portfolio	0	Q3 2024 New
TERN Terns Pharmaceuticals, Inc.	$191M	$0 0.0% of portfolio	0	Q3 2024 New
TGTX Tg Therapeutics, Inc.	$4.2B	$0 0.0% of portfolio	0	Q3 2024 New
TBPH Theravance Biopharma, Inc.	$586M	$0 0.0% of portfolio	0	Q3 2024 New
THRD Third Harmonic Bio, Inc.	$337M	$0 0.0% of portfolio	0	Q3 2024 New
TLSA Tiziana Life Sciences LTD	$83.9M	$0 0.0% of portfolio	0	Q3 2024 New
TVTX Travere Therapeutics, Inc.	$1.16B	$0 0.0% of portfolio	0	Q3 2024 New
TRVI Trevi Therapeutics, Inc.	$228M	$0 0.0% of portfolio	0	Q3 2024 New
TCDA Tricida, Inc.	$557K	$0 0.0% of portfolio	0	Q3 2024 New
TCRX T Scan Therapeutics, Inc.	$51.5M	$0 0.0% of portfolio	0	Q3 2024 New
TYRA Tyra Biosciences, Inc.	$638M	$0 0.0% of portfolio	0	Q3 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$2.95B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
UNCY Unicycive Therapeutics, Inc.	$10.2M	$0 0.0% of portfolio	0	Q3 2024 New
QURE Uni Qure N.V.	$647M	$0 0.0% of portfolio	0	Q3 2024 New
UTHR United Therapeutics Corp	$16.6B	$0 0.0% of portfolio	0	Q3 2024 Sold Out
URGN Uro Gen Pharma Ltd.	$233M	$0 0.0% of portfolio	0	Q3 2024 New
VACC Vaccitech PLC	$127M	$0 0.0% of portfolio	0	Q3 2024 New
VALN Valneva Se	$314M	$0 0.0% of portfolio	0	Q3 2024 New
VNDA Vanda Pharmaceuticals Inc.	$260M	$0 0.0% of portfolio	0	Q3 2024 New
VXRT Vaxart, Inc.	$99.9M	$0 0.0% of portfolio	0	Q3 2024 New
PCVX Vaxcyte, Inc.	$4.81B	$0 0.0% of portfolio	3	Q3 2024 New
VTYX Ventyx Biosciences, Inc.	$118M	$0 0.0% of portfolio	0	Q3 2024 New
VERA Vera Therapeutics, Inc.	$1B	$0 0.0% of portfolio	0	Q3 2024 New
VCYT Veracyte, Inc.	$2.97B	$0 0.0% of portfolio	0	Q3 2024 New
VCEL Vericel Corp	$2.81B	$0 0.0% of portfolio	0	Q3 2024 New
VRNA Verona Pharma PLC	$2.76B	$0 0.0% of portfolio	0	Q3 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$0 0.0% of portfolio	0	Q3 2024 New
VERU Veru Inc.	$62.5M	$0 0.0% of portfolio	0	Q3 2024 New
VERV Verve Therapeutics, Inc.	$331M	$0 0.0% of portfolio	0	Q3 2024 New
VIGL Vigil Neuroscience, Inc.	$50.6M	$0 0.0% of portfolio	0	Q3 2024 New
VINC Vincerx Pharma, Inc.	$4.24M	$0 0.0% of portfolio	0	Q3 2024 New
VIR Vir Biotechnology, Inc.	$1.6B	$0 0.0% of portfolio	0	Q3 2024 New
VIRX Viracta Therapeutics, Inc.	$7.14M	$0 0.0% of portfolio	0	Q3 2024 New
VRDN Viridian Therapeutics, Inc.\De	$726M	$0 0.0% of portfolio	0	Q3 2024 New
VIRI Virios Therapeutics, Inc.	$81.4M	$0 0.0% of portfolio	0	Q3 2024 New
VOR Vor Biopharma Inc.	$59.4M	$0 0.0% of portfolio	0	Q3 2024 New
VYGR Voyager Therapeutics, Inc.	$211M	$0 0.0% of portfolio	0	Q3 2024 New
VYNE Vyne Therapeutics Inc.	$209M	$0 0.0% of portfolio	0	Q3 2024 New
WVE Wave Life Sciences Ltd.	$1B	$0 0.0% of portfolio	0	Q3 2024 New
HOWL Werewolf Therapeutics, Inc.	$40.8M	$0 0.0% of portfolio	0	Q3 2024 New
WINT Windtree Therapeutics Inc	$7.96M	$0 0.0% of portfolio	0	Q3 2024 New
XFOR X4 Pharmaceuticals, Inc	$40.5M	$0 0.0% of portfolio	0	Q3 2024 New
XBIT X Biotech Inc.	$118M	$0 0.0% of portfolio	0	Q3 2024 New
XNCR Xencor Inc	$1.23B	$0 0.0% of portfolio	0	Q3 2024 New
XERS Xeris Biopharma Holdings, Inc.	$462M	$0 0.0% of portfolio	0	Q3 2024 New
XLO Xilio Therapeutics, Inc.	$30.2M	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.